Could a Two-Drug combo finally cure chronic hepatitis b?
⭐️ CURE ⭐️
Ongoing
This study tests whether adding a PD-1 antibody (sintilimab) and pegylated interferon to standard antiviral therapy can cure chronic hepatitis B. The goal is to eliminate the hepatitis B surface antigen (HBsAg) from the blood, which would mean the virus is no longer active. The s…
Phase: NA • Sponsor: Beijing 302 Hospital • Aim: ⭐️ CURE ⭐️
Last updated May 14, 2026 12:06 UTC